Improving Communication in Older Cancer Patients and Their Caregivers
Public ClinicalTrials.gov record NCT02107443. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Over 60% of cancers occur in older persons, and the number of older persons with cancer is expected to grow as the population ages. Oncology clinical trials have traditionally excluded older patients with advanced cancer and chronic health conditions. In this context, where data is limited and risk from treatment is high, older patients with advanced cancer and their caregivers must understand how cancer treatment can affect quality of life in light of underlying health status. Better communication about age-related health conditions between oncologists, older patients with advanced cancer, and their caregivers may improve decision-making for cancer treatment and quality of life. A geriatric assessment (GA), a validated set of patient-centered outcomes, has been shown to identify concerns (e.g., function, cognition) important to older persons with cancer and their caregivers. In this cluster randomized clinical trial we examined whether providing a web-generated GA summary with targeted recommendations to older patients with advanced cancer, their caregivers, and their oncologists can improve communication about age-related concerns that could affect efficacy and tolerance of cancer treatment. We also determined whether the intervention improves patient-reported quality of life and patient and caregiver satisfaction.
Study identification
- NCT ID
- NCT02107443
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 546 participants
Conditions and interventions
Conditions
Interventions
- Geriatric Assessment Summary Behavioral
- Geriatric Assessment Targeted Recommendations Behavioral
- Geriatric Assessment (GA) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 70 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2014 (Actual)
- Primary completion
- May 12, 2017 (Actual)
- Completion
- Sep 1, 2020 (Actual)
- Last update posted
- Apr 12, 2024
2014 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | — |
| Delaware/Christiana Care NCORP | Newark | Delaware | 19713 | — |
| Hawaii | Honolulu | Hawaii | 96813 | — |
| University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637 | — |
| Heartland NCORP | Decatur | Illinois | 62526 | — |
| Kansas City NCORP | Prairie Village | Kansas | 66208 | — |
| Wichita NCORP | Wichita | Kansas | 67214 | — |
| Michigan Cancer Research Consortium | Ann Arbor | Michigan | 48106 | — |
| Metro-Minnesota NCORP | Minneapolis | Minnesota | 55426 | — |
| Nevada NCORP | Las Vegas | Nevada | 89106 | — |
| Northwell Health | Lake Success | New York | 11042 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Southeast Clinical Oncology Research Consortium | Winston-Salem | North Carolina | 27104 | — |
| Columbus NCORP | Columbus | Ohio | 43215 | — |
| Pacific Cancer Research Consortium Ncorp | Portland | Oregon | 97213 | — |
| Geisinger Cancer Institute NCORP | Danville | Pennsylvania | 17822 | — |
| Greenville NCORP | Greenville | South Carolina | 29615 | — |
| WiNCORP | Marshfield | Wisconsin | 54449 | — |
| Aurora NCORP | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02107443, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2024 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02107443 live on ClinicalTrials.gov.